CSF3 and metabolic dysfunction-associated steatotic liver disease: The importance of this gene in NAFLD is described by Nam et al., in which they demonstrate that a treatment with CSF3 in animal models had a possible protective effect by reducing hepatocyte apoptosis and by increasing cell survival and the anti-inflammatory function [98].